Avanos Medical, Inc.
US ˙ NYSE ˙ US05350V1061

SecurityAVNS / Avanos Medical, Inc.
InstitutionParallel Advisors, LLC
Latest Disclosed Ownership63 shares
Latest Disclosed Value $ 707
Parallel Advisors, LLC ownership in AVNS / Avanos Medical, Inc.

On February 11, 2026 - Parallel Advisors, LLC filed a 13F-HR form disclosing ownership of 63 shares of Avanos Medical, Inc. (US:AVNS) valued at $707 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 383 shares of Avanos Medical, Inc.. This represents a change in shares of -83.55% during the quarter. The current value of the position is $1,574 USD.

Parallel Advisors, LLC has a history of taking positions in derivatives of the underlying security (AVNS) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AVNS / Avanos Medical, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F AVANOS MED INC COM Stock 05350V106 63 -320 -83.55 1 -100.00 0.0000
2025-11-13 2025-09-30 13F AVANOS MED INC COM Stock 05350V106 383 -9 -2.30 4 0.00 0.0001
2025-07-08 2025-06-30 13F AVANOS MED INC COM Stock 05350V106 392 -841 -68.21 5 -76.47 0.0001
2025-04-08 2025-03-31 13F AVANOS MED INC COM Stock 05350V106 1,233 857 227.93 18 240.00 0.0004
2025-02-10 2024-12-31 13F AVANOS MED INC COM Stock 05350V106 376 297 375.95 6 400.00 0.0001
2024-11-13 2024-09-30 13F AVANOS MED INC COM Stock 05350V106 79 -14 -15.05 2 0.00 0.0000
2024-08-08 2024-06-30 13F AVANOS MED INC COM Stock 05350V106 93 -39 -29.55 2 -50.00 0.0000
2024-05-06 2024-03-31 13F AVANOS MED INC COM Stock 05350V106 132 64 94.12 3 100.00 0.0001
2024-02-12 2023-12-31 13F AVANOS MED INC COM Stock 05350V106 68 -7 -9.33 2 0.00 0.0000
2024-05-20 2023-09-30 13F/A-1 AVANOS MED INC COM Stock 05350V106 75 -35 -31.82 2 -50.00 0.0001
2023-11-14 2023-09-30 13F AVANOS MED INC COM Stock 05350V106 75 -35 2 0.0001
2024-05-20 2023-06-30 13F/A-1 AVANOS MED INC COM Stock 05350V106 110 0 0.00 3 -33.33 0.0001
2023-08-04 2023-06-30 13F AVANOS MED INC COM Stock 05350V106 110 0 3 0.0001
2024-05-20 2023-03-31 13F/A-1 AVANOS MED INC COM Stock 05350V106 110 0 0.00 3 50.00 0.0001
2023-04-25 2023-03-31 13F AVANOS MED INC COM Stock 05350V106 110 0 3 0.0001
2023-02-06 2022-12-31 13F AVANOS MED INC COM Stock 05350V106 110 0 0.00 3 0.00 0.0001
2022-11-10 2022-09-30 13F AVANOS MED INC COM Stock 05350V106 110 12 12.24 2 -33.33 0.0001
2022-08-01 2022-06-30 13F AVANOS MED INC COM Stock 05350V106 98 0 0.00 3 0.00 0.0001
2022-04-28 2022-03-31 13F AVANOS MED INC COM Stock 05350V106 98 32 48.48 3 50.00 0.0001
2022-01-20 2021-12-31 13F AVANOS MED INC COM Stock 05350V106 66 0 0.00 2 0.00 0.0001
2021-11-02 2021-09-30 13F/A-1 AVANOS MED INC COM Stock 05350V106 66 0 0.00 2 0.00 0.0001
2021-08-06 2021-06-30 13F AVANOS MED INC COM Stock 05350V106 66 0 0.00 2 -33.33 0.0001
2021-04-23 2021-03-31 13F AVANOS MED INC COM Stock 05350V106 66 0 0.00 3 0.00 0.0001
2021-02-02 2020-12-31 13F AVANOS MED INC COM Stock 05350V106 66 0 0.00 3 50.00 0.0002
2020-10-27 2020-09-30 13F AVANOS MED INC COM Stock 05350V106 66 31 88.57 2 100.00 0.0001
2020-07-16 2020-06-30 13F AVANOS MED INC COM Stock 05350V106 35 -13 -27.08 1 0.00 0.0001
2020-04-27 2020-03-31 13F AVANOS MED INC COM Stock 05350V106 48 -2 -4.00 1 -50.00 0.0001
2020-01-30 2019-12-31 13F AVANOS MED INC COM Stock 05350V106 50 0 0.00 2 0.00 0.0002
2019-11-01 2019-09-30 13F AVANOS MED INC COM Stock 05350V106 50 0 0.00 2 0.00 0.0002
2019-08-05 2019-06-30 13F AVANOS MED INC COM Stock 05350V106 50 0 0.00 2 0.00 0.0002
2019-05-01 2019-03-31 13F AVANOS MED INC COM Stock 05350V106 50 0 0.00 2 0.00 0.0002
2019-02-05 2018-12-31 13F AVANOS MED INC COM Stock 05350V106 50 0 0.00 2 -33.33 0.0003
2018-11-01 2018-09-30 13F AVANOS MED INC COM Stock 05350V106 50 0 0.00 3 50.00 0.0004
2018-07-30 2018-06-30 13F AVANOS MED INC COM Stock 05350V106 50 -2 -3.85 2 0.00 0.0003
2018-05-08 2018-03-31 13F HALYARD HEALTH INC COM Stock 40650V100 52 0 0.00 2 0.00 0.0003
2018-02-13 2017-12-31 13F HALYARD HEALTH INC COM Stock 40650V100 52 0 0.00 2 0.00 0.0003
2017-11-15 2017-09-30 13F/A-1 HALYARD HEALTH INC COM Stock 40650V100 52 0 0.00 2 0.00 0.0003
2017-08-07 2017-06-30 13F HALYARD HEALTH INC COM Stock 40650V100 52 0 0.00 2 0.00 0.0004
2017-05-12 2017-03-31 13F/A-1 HALYARD HEALTH INC COM Stock 40650V100 52 0 0.00 2 0.00 0.0004
2017-05-12 2017-03-31 13F HALYARD HEALTH INC COM Stock 40650V100 52 2
2017-02-14 2016-12-31 13F HALYARD HEALTH INC COM Stock 40650V100 52 52 2 0.0005
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-01-19 2021-12-31 13F AVANOS MED INC COM Stock Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-10-22 2021-09-30 13F AVANOS MED INC COM Stock Call 66 2 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.